<!DOCTYPE html>
<html lang="en">
<head>
<?php $id='1936-1239'; include '../../seo.php';?>
<?php include '../../side-nav.php';?>
<div class="page-content">
<!--section-->
<div class="section mt-0">
<div class="breadcrumbs-wrap">
<div class="container">
<div class="breadcrumbs">
<a href="https://sprintdiagnostics.in/">Home</a>
<a href="https://www.sprintdiagnostics.in/hyderabad/test/">Test</a>
<span>CML Quant</span>
</div>
</div>
</div>
</div>
<!--//section-->
<!--section-->
<div class="section page-content-first">
<div class="container mt-6">
<div class="row">
<div class="col-md-8 col-lg-8 mt-0 mt-md-0 mb-4">
<h1 class="test-h1">CML Quant: Chronic Myeloid Leukemia with Karyotyping and BCR/ABL - IS by PCR Quantitative </h1>
<div class="post-text">
<p> Chronic Myeloid Leukemia (CML) is a form of leukemia characterized by the abnormal growth of myeloid cells in the bone marrow and their accumulation in the blood. CML is a genetic disease and is most often associated with a specific chromosomal abnormality known as the Philadelphia chromosome. The Philadelphia chromosome arises from a reciprocal translocation between chromosomes 9 and 22, which results in the BCR-ABL fusion gene. The protein produced by this gene is a tyrosine kinase that promotes cell proliferation, contributing to the development of leukemia. <br><br>
CML Quant is a testing approach that includes Karyotyping and BCR/ABL International Scale (IS) by Polymerase Chain Reaction (PCR) Quantitative. Karyotyping is used to visualize the chromosomes in the cells, which can confirm the presence of the Philadelphia chromosome. BCR/ABL - IS by PCR Quantitative is a highly sensitive method that measures the levels of the BCR-ABL fusion gene and is used to monitor the patient’s response to therapy over time.</p>
<p> </p>
<div class="table-wrap">
<table class="table table-striped">
	<thead>
		<tr>
			<th scope="col">Test Name</th>
			<td scope="col">CML Quant: Chronic Myeloid Leukemia with Karyotyping and BCR/ABL - IS by PCR Quantitative </td>
		</tr>
	</thead>
	<tbody>
		<tr>
			<th scope="row">Sample Type</th>
			<td>Blood/Bone Marrow </td>
		</tr>
		<tr>
			<th scope="row">Preparations Required</th>
			<td> No fasting is required. It is crucial to adhere to any instructions given by your doctor, and to inform them of any medications being taken. </td>
		</tr>
		<tr>
			<th scope="row">Report Time</th>
			<td>10 Days for cytogenetics / 5 Days for PCR. </td>
		</tr>
		<tr>
			<th scope="row">Price in Hyderabad</th>
			<td>₹ 10000 </td>
		</tr>
	</tbody>
</table>
</div>
<div class="post-text">
	<h2 class="test-h2 mt-3">What is Chronic Myeloid Leukemia (CML)? </h2>
	<p>Chronic Myeloid Leukemia is a type of cancer that starts in the blood-forming cells in the bone marrow. It is characterized by the uncontrolled growth of myeloid cells in the bone marrow and their accumulation in the blood. CML is associated with a specific genetic abnormality called the Philadelphia chromosome. </p>
	<h2 class="test-h2 mt-3">What is the role of Karyotyping in CML diagnosis? </h2>
	<p>Karyotyping is a laboratory procedure that allows for the visualization of an individual's chromosomes. In CML, karyotyping is important for the identification of the Philadelphia chromosome, which is a hallmark of this disease.
	 </p>
	<!--section achieved-->
	<?php include "../../include/iconsbox.php" ?>
	<!--//section achieved-->
	<h2 class="test-h2 mt-3">What does BCR/ABL - IS by PCR Quantitative measure? </h2>
	<p>BCR/ABL - IS by PCR Quantitative measures the amount of BCR-ABL fusion gene in blood or bone marrow. This test is highly sensitive and is used to monitor how well a patient with CML is responding to treatment. </p>
	<h2 class="test-h2 mt-3">Why is it essential to measure the BCR/ABL fusion gene? </h2>
	<p>Measurement of the BCR/ABL fusion gene is important for the diagnosis and monitoring of CML. It helps to confirm the diagnosis and to evaluate how well the disease is responding to treatment. Additionally, it can be used to detect minimal residual disease in patients in remission. </p>
	<h2 class="test-h2 mt-3">How often should CML Quant be performed? </h2>
	<p>The frequency of CML Quant testing depends on the stage of the disease and how well the patient is responding to treatment. It is usually done at diagnosis and regularly thereafter to monitor the response to therapy. </p>
	<h2 class="test-h2 mt-3">What are the treatment options for CML? </h2>
	<p>The primary treatment for CML is tyrosine kinase inhibitors, which target the BCR-ABL protein. Other treatments may include chemotherapy, bone marrow transplantation, and immunotherapy. </p>
	<h2 class="test-h2 mt-3">Are there any lifestyle changes recommended for patients with CML? </h2>
	<p>Patients with CML should maintain a balanced diet, engage in regular physical activity, avoid tobacco and limit alcohol consumption. It is also important to adhere to the treatment regimen and follow-up appointments as recommended by the doctor. </p>
	<h2 class="test-h2 mt-3">Can CML be cured? </h2>
	<p>While CML can often be controlled with medication, especially if diagnosed early, it may not be curable in all patients. However, some patients may achieve a deep molecular response, which means that the disease is not detectable with the most sensitive tests. </p>
	<h2 class="test-h2 mt-3">What are the risks associated with CML treatments? </h2>
	<p>CML treatments, particularly tyrosine kinase inhibitors, can have side effects such as fatigue, nausea, muscle cramps, and changes in blood counts. It is important to communicate with the doctor about any side effects experienced during treatment. </p>
	<h2 class="test-h2 mt-3">Which doctor should be consulted if diagnosed with CML? </h2>
	<p>If diagnosed with Chronic Myeloid Leukemia, it is essential to consult a hematologist or oncologist who specializes in the treatment of blood cancers. </p>
	<h2 class="test-h2 mt-3">Are there support groups for patients with CML? </h2>
	<p>Yes, there are support groups and organizations that offer help and support to individuals with CML and their families. </p>
	<h2 class="test-h2 mt-3">Is CML hereditary? </h2>
	<p>CML is not typically hereditary. It is caused by a genetic change that occurs during a person’s lifetime. <br><br>
CML Quant testing is a comprehensive approach to the diagnosis and monitoring of Chronic Myeloid Leukemia. Karyotyping helps in identifying the Philadelphia chromosome, while BCR/ABL - IS by PCR Quantitative measures the level of the BCR-ABL fusion gene to monitor the response to treatment. Regular monitoring and adherence to the treatment regimen are vital in managing CML. Communication with the treating doctor is imperative for comprehensive care and management.
 </p>

</div>		
</div>			
</div>
<!--form section-->
<?php include "../../include/bookslot.php" ?>
<!--form section-->
</div>
</div>
<!--//section-->
</div>
</div>
<?php include '../../footer.php';?>
</body>
</html>